By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


Key Statistics


Email:
Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






Company News
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary 10/30/2014 6:25:44 AM
Gilead Sciences, Inc. (GILD) Announces Third Quarter 2014 Financial Results 10/29/2014 8:53:54 AM
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst 10/27/2014 3:16:19 PM
AHF To Gilead Sciences, Inc. (GILD): Do Your Patriotic Duty And Lower Hep. C Drug Prices For Veterans 10/24/2014 11:29:17 AM
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014 7:42:36 AM
Gilead Sciences, Inc. (GILD) To Release Third Quarter 2014 Financial Results On Tuesday, October 28, 2014 10/22/2014 9:40:49 AM
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/20/2014 7:33:06 PM
Gilead Sciences, Inc. (GILD) To Create More Than 80 Jobs With $50 Million Expansion 10/20/2014 7:30:46 PM
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014 7:14:37 AM
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014 12:56:35 PM
12345678910...
//-->